Tag: biosimilars

The Purple Book: Understanding Biosimilars and Interchangeability from the FDA

The Purple Book: Understanding Biosimilars and Interchangeability from the FDA

The FDA's Purple Book is the official source for understanding which biological drugs are biosimilars and which can be swapped at the pharmacy. Learn how interchangeability works, why it matters, and how to use the database.

Global Biosimilar Markets: Europe vs United States - How Regulations and Adoption Diverge

Global Biosimilar Markets: Europe vs United States - How Regulations and Adoption Diverge

Europe led the world in biosimilar adoption with clear regulations and high uptake. The US lagged due to patents and strict rules-but is now accelerating fast. Here's how the two markets compare today and where they're headed.